P Specenier
Overview
Explore the profile of P Specenier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
256
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Quinten C, Kenis C, Decoster L, Debruyne P, De Groof I, Focan C, et al.
Qual Life Res
. 2018 Dec;
28(3):663-676.
PMID: 30511255
Purpose: Using the EORTC Global Health Status (GHS) scale, we aimed to determine minimal clinically important differences (MCID) in health-related quality of life (HRQOL) changes for older cancer patients with...
2.
Kenis C, Decoster L, Flamaing J, Debruyne P, De Groof I, Focan C, et al.
Ann Oncol
. 2018 Jun;
29(9):1987-1994.
PMID: 29905766
Background: In the general older population, geriatric assessment (GA)-guided treatment plans can improve overall survival, quality of life and functional status (FS). In GA-related research in geriatric oncology, studies mainly...
3.
Strens D, Specenier P, Peeters M
Value Health
. 2016 May;
17(7):A627.
PMID: 27202222
No abstract available.
4.
Van den Bossche J, Lardon F, Deschoolmeester V, De Pauw I, Vermorken J, Specenier P, et al.
Med Res Rev
. 2016 May;
36(4):749-86.
PMID: 27140825
Considering the important side effects of conventional microtubule targeting agents, more and more research focuses on regulatory proteins for the development of mitosis-specific agents. Polo-like kinase 1 (Plk1), a master...
5.
Kenis C, Heeren P, Decoster L, Van Puyvelde K, Conings G, Cornelis F, et al.
J Nutr Health Aging
. 2016 Jan;
20(1):60-70.
PMID: 26728935
Objectives: The aim of this study is to describe a large-scale, Belgian implementation project about geriatric assessment (=GA) in daily oncology practice and to identify barriers and facilitators for implementing...
6.
Machiels J, Specenier P, Krauss J, Dietz A, Kaminsky M, Lalami Y, et al.
Cancer Chemother Pharmacol
. 2015 May;
76(1):13-20.
PMID: 25952795
Purpose: The purpose of the trial was to assess the efficacy and tolerability of Sym004, a novel 1:1 mixture of two chimeric monoclonal antibodies (992 and 1024) targeting non-overlapping epitopes...
7.
Vermorken J, Specenier P
Ann Oncol
. 2010 Oct;
21 Suppl 7:vii252-61.
PMID: 20943624
While a large proportion of patients presenting with stage I and II squamous cell carcinoma of the head and neck (SCCHN) will remain disease free after single modality treatment, the...
8.
Specenier P, Guetens G, Dyck J, De Boeck G, Weyler J, Van den Weyngaert D, et al.
Cancer Chemother Pharmacol
. 2010 Oct;
68(1):185-91.
PMID: 20882386
Purpose: The aim of this study was to investigate whether relevant plasma levels of dFdU could be detected during concurrent chemoradiation (CRT) with low doses of dFdC administered in patients...
9.
van Ierssel S, Specenier P, Baar I, De Belder F, Jorens P, Vermorken J
Acta Clin Belg
. 2010 Apr;
65(1):51-3.
PMID: 20373600
Central venous catheters are widely used in clinical practice. Air embolism is a rare, but potentially life threatening complication of central venous catheterisation. We describe a case of collapse and...
10.
Specenier P, Koppen C, Vermorken J
Ann Oncol
. 2007 Apr;
18(5):961-2.
PMID: 17442661
No abstract available.